Ronald Loucks - NexgenRX President CEO, Director
| NXG Stock | CAD 0.22 0.02 10.00% |
CEO
Mr. Ronald C. Loucks is President, Chief Executive Officer and Director of NexgenRx Inc. He is Former Executive VicePresident and Chief Operating Officer of, Assure Health Inc., from May 1989 through October 1999 and upon the sale of Assure Health Inc. to BCE Emergis Inc., he was the Executive VicePresident, eHealth North America, from November 1999 through February 2002. He is Currently a member of the Board of Governors of McMaster University and serves on the Board of Directors of ThinkFirst Canada. since 2003.
| Tenure | 21 years |
| Address | 191 The West Mall, Toronto, ON, Canada, M9C 5L6 |
| Phone | 416-695-3393 |
| Web | https://www.nexgenrx.com |
NexgenRX Management Efficiency
At this time, NexgenRX's Net Tangible Assets are fairly stable compared to the past year. Other Assets is likely to climb to about 2.1 M in 2024, whereas Total Current Assets are likely to drop slightly above 13.1 M in 2024. NexgenRX's management efficiency ratios could be used to measure how well NexgenRX manages its routine affairs as well as how well it operates its assets and liabilities.Management Performance
| Return On Equity | -0.0401 | ||||
| Return On Asset | -0.0032 |
NexgenRX Leadership Team
Elected by the shareholders, the NexgenRX's board of directors comprises two types of representatives: NexgenRX inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NexgenRX. The board's role is to monitor NexgenRX's management team and ensure that shareholders' interests are well served. NexgenRX's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NexgenRX's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Taba Merrikh, Acting CFO | ||
| David Rosenkrantz, Independent Director | ||
| Ronald BBA, CEO, Founder | ||
| Ronald Loucks, President CEO, Director | ||
| Patrick Crowley, Director | ||
| MBA LLB, Company Secretary | ||
| Avik Debroy, Financial Controller | ||
| Ralph Soberano, Director | ||
| Jason Robinson, Senior Administration | ||
| Barry Reiter, Director | ||
| Andrew Munroe, Senior Partners | ||
| Kelly Ehler, Interim CFO | ||
| Randy McGlynn, Director | ||
| Thomas Corcoran, Chairman of the Board | ||
| Doreen Harvey, Lead Resources |
NexgenRX Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is NexgenRX a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0401 | ||||
| Return On Asset | -0.0032 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | (0.07) % | ||||
| Current Valuation | 15.75 M | ||||
| Shares Outstanding | 70.53 M | ||||
| Shares Owned By Insiders | 36.63 % | ||||
| Number Of Shares Shorted | 1.04 K | ||||
| Price To Earning | 76.67 X | ||||
| Price To Book | 2.73 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NexgenRX in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NexgenRX's short interest history, or implied volatility extrapolated from NexgenRX options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NexgenRX. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for NexgenRX Stock analysis
When running NexgenRX's price analysis, check to measure NexgenRX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NexgenRX is operating at the current time. Most of NexgenRX's value examination focuses on studying past and present price action to predict the probability of NexgenRX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NexgenRX's price. Additionally, you may evaluate how the addition of NexgenRX to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |